KISHORE MASURKAR

Entod Pharmaceuticals inaugurates R&D centre in Navi Mumbai

The facility will focus on developing next-generation molecules using generative artificial intelligence (AI) platforms, particularly in the ophthalmic, ENT, paediatric, and skin care segments. Some of these molecules are expected to be indigenous to India.